7
The included in vitro studies have tested thyroid toxicity for a wide range of endpoints (Table 1) , but not all 139 chemicals have been tested for all relevant mechanisms of thyroid toxicity. This approach, which includes a 140 range of assays, is analogous to classical risk assessment where several endpoints are evaluated and only the 141 most sensitive endpoint is used in the end. 144 Ranking of the five compounds in terms of calculated RCR values based on in vitro NOEC values showed 145 that PFOS was associated with the highest risk (RCR = 8) and HBCD with the lowest (RCR=0.0001) ( Table   146 2): Based on this analysis, exposure to PFOS alone is highlighted as a potential human health risk. The 151 association is of even greater concern considering that humans are exposed to several perfluorinated 152 compounds [36] that may have the same or similar mode(s) of action, which can cause cumulative effects. 153 The RCR ranking shows that PFOS needs further attention, although its use is restricted within the US [37] 154 and EU [38] . 155 It should be noted, however, that the RCR values are subject to great uncertainties, both for the hazard and As can be seen in Fig. 2 the in vitro active concentrations and the blood levels at LOAELs and/or NOAELs 160 from animal experiments were not that different. However, for PFOS effects are seen at lower concentrations 161 in vitro than in vivo, whereas for triclosan the situation is opposite. This reflects that toxicity of some 162 perfluorinated chemicals generally seem to be underestimated by animal studies [39] and that human data 173 We found limited relevant in vitro data and data that covers thyroid toxic mode(s) of action and/or key 174 initiating events for the selected chemicals. Furthermore, there is a need for more human-based in vitro 175 models as we in this case study only found a few assays based on human biology. 176 We suggest that defined panels of human-based in vitro assays are used to ensure that several important 
Output and ranking

A panel of human-based in vitro assays
211
Bioactive in vitro concentrations were extrapolated to oral equivalent doses by reverse dosimetry, and these 212 doses were compared to external exposure doses calculated from HBM data. If the estimated exposure is 213 higher than the dose needed to obtain a bioactive concentration in blood, a potential risk is identified. 214 Interestingly, in that study triclosan was identified as one of the compounds with the smallest difference 215 between exposure and activity, i.e. as the most problematic and a priority for further evaluation [18] . 
Conclusion
224
We used a case study on five thyroid toxic compounds with differential mechanistic profiles to investigate 225 the potential use of human biomonitoring (HBM) together with in vitro data for informing human risk 226 assessment. We conclude that calculation of risk characterization ratios based on HBM and in vitro data is a 227 helpful tool for ranking chemicals and for designing follow-up studies.
228
The case study highlighted the pros and cons of informing the risk assessment process with in vitro and 229 HBM data and demonstrated that such data can be used for risk ranking of chemicals. Moreover, this 230 approach may be used for pinpointing chemicals for which species differences may play a major role, 231 thereby stressing the importance of basing the risk assessment on human-relevant data. Our vision is that an 232 in vitro/HBM approach can use the HBM4EU project -in parallel to the NHANES project in the US -233 together with more comprehensive human relevant in vitro data to make 'alternative' risk assessment much 234 more valuable to finally be able to 'stand-alone'.
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